The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10,000 deeply phenotyped adults in Germany.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Loeffler Markus, Engel Christoph, Ahnert Peter, Alfermann Dorothee, Arelin Katrin, Baber Ronny, Beutner Frank, Binder Hans, Brähler Elmar, Burkhardt Ralph, Ceglarek Uta, Enzenbach Cornelia, Fuchs Michael, Glaesmer Heide, Girlich Friederike, Hagendorff Andreas, Häntzsch Madlen, Hegerl Ulrich, Henger Sylvia, Hensch Tilman, Hinz Andreas, Holzendorf Volker, Husser Daniela, Kersting Anette, Kiel Alexander, Kirsten Toralf, Kratzsch Jürgen, Krohn Knut, Luck Tobias, Melzer Susanne, Netto Jeffrey, Nüchter Matthias, Raschpichler Matthias, Rauscher Franziska G, Riedel-Heller Steffi G, Sander Christian, Scholz Markus, Schönknecht Peter, Schroeter Matthias L, Simon Jan-Christoph, Speer Ronald, Stäker Julia, Stein Robert, Stöbel-Richter Yve, Stumvoll Michael, Tarnok Attila, Teren Andrej, Teupser Daniel, Then Francisca S, Tönjes Anke, Treudler Regina, Villringer Arno, Weissgerber Alexander, Wiedemann Peter, Zachariae Silke, Wirkner Kerstin, Thiery Joachim
Аннотация
METHODS/DESIGN: The study covers a main age range from 40-79 years with particular deep phenotyping in elderly participants above the age of 60. The baseline examination was conducted from August 2011 to November 2014. All participants underwent an extensive core assessment programme (5-6 h) including structured interviews, questionnaires, physical examinations, and biospecimen collection. Participants over 60 underwent two additional assessment programmes (3-4 h each) on two separate visits including deeper cognitive testing, brain magnetic resonance imaging, diagnostic interviews for depression, and electroencephalography.
DISCUSSION: The participation rate was 33 %. The assessment programme was accepted well and completely passed by almost all participants. Biomarker analyses have already been performed in all participants. Genotype, transcriptome and metabolome analyses have been conducted in subgroups. The first follow-up examination will commence in 2016.